(GLP-1 RA)1 How often do you prescribe RYBELSUS® to your T2D patients for glycemic control? Select one to get info that’s relevant to you. Rarely or never A few times a month A few times a week GLP-1 RA=glucagon-like peptide-1 receptor agonist; T2D=type 2 diabetes....
This open label clinical trial spurred a larger double-blind, randomized, placebo-controlled trial by the same group that evaluated once weekly extended-release exenatide (Bydureon®) in moderate PD patients and reported significantly improved off-medication motor scores [13] assessed by MDS-UPDRS ...
The recent inclusion of once-a-week dose drugs, Dulaglutide and albiglutide, can improve the adherence of medication by patients but the expense and limited clinical experience by health care professionals are the points of concern. Compared to all other marketed GLP-1R, epfeglenatide shows the ...
The reason for dropout maybe withdrawal of consent, adverse event, pregnancy discovered during the trial or failure to comply with clinical trial medication or protocol. If the patient misses more than one injection or more than one visit in total, she will be excluded. Randomization The patients...
However, cost and risk associated with medication with such synthetic drugs trigger exploration of alternatives in the form of herbal preparations and formulations, which unarguably remain the unmatched source of drug leads and an alternative to modern allopathic medicine globally. Ayurveda, Siddha, ...
However, medication and insulin therapy can still be necessary for optimal glycemic control [12,13]. Early detection and intervention are crucial for preventing and managing diabetes and its complications, while regular blood glucose monitoring is highly recommended for all diabetes patients. Moreover,...